Region-Specific Effects of Trigeminal Capsaicin Stimulation
Standard
Region-Specific Effects of Trigeminal Capsaicin Stimulation. / Poulsen, Catharina Egholm; Bendixen, Karina Haugaard; Terkelsen, Astrid Juhl; May, Arne; Hansen, John; Svensson, Peter.
in: J ORAL FACIAL PAIN H, Jahrgang 33, Nr. 3, 2019, S. 318–330.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Region-Specific Effects of Trigeminal Capsaicin Stimulation
AU - Poulsen, Catharina Egholm
AU - Bendixen, Karina Haugaard
AU - Terkelsen, Astrid Juhl
AU - May, Arne
AU - Hansen, John
AU - Svensson, Peter
PY - 2019
Y1 - 2019
N2 - AIMS: To investigate the region-specific effects of painful trigeminal capsaicin stimulation in healthy participants.METHODS: Twenty healthy participants (10 men and 10 women) participated in four sessions in which they received application of 0.05 mL Vaseline (placebo) or capsaicin cream (0.1%) to a different area innervated by the three branches of the trigeminal nerve: the supraorbital area (V1), the nasal mucosa (V1/V2), and the maxillary (V2) and mandibular (V3) oral mucosa. The participants rated their perceived sensations on a 0-50-100 numeric rating scale (NRS). Thermal (5°C, 23°C, and 50°C) and mechanical (32 mN and 256 mN) sensitivities were assessed. The Schirmer tearing test was used to monitor the lacrimation level as a local measure of autonomic activity, and the Task Force Monitor was used to record systemic autonomic activity. Data were analyzed using repeated measures analysis of variance.RESULTS: Capsaicin application evoked significantly higher overall NRS scores (P < .001) and induced significantly higher ratings to the heat stimuli (P < .009) in all sessions compared to control. For lacrimation level, capsaicin stimulation resulted in a significant increase compared to control (P < .0002) only in the nasal mucosa session.CONCLUSION: Topical application of capsaicin cream to the different branches of the trigeminal nerve caused higher NRS scores along with an altered somatosensory sensitivity. Furthermore, in the nasal mucosa session, a robust local and generalized parasympathetic activation appeared following capsaicin application.
AB - AIMS: To investigate the region-specific effects of painful trigeminal capsaicin stimulation in healthy participants.METHODS: Twenty healthy participants (10 men and 10 women) participated in four sessions in which they received application of 0.05 mL Vaseline (placebo) or capsaicin cream (0.1%) to a different area innervated by the three branches of the trigeminal nerve: the supraorbital area (V1), the nasal mucosa (V1/V2), and the maxillary (V2) and mandibular (V3) oral mucosa. The participants rated their perceived sensations on a 0-50-100 numeric rating scale (NRS). Thermal (5°C, 23°C, and 50°C) and mechanical (32 mN and 256 mN) sensitivities were assessed. The Schirmer tearing test was used to monitor the lacrimation level as a local measure of autonomic activity, and the Task Force Monitor was used to record systemic autonomic activity. Data were analyzed using repeated measures analysis of variance.RESULTS: Capsaicin application evoked significantly higher overall NRS scores (P < .001) and induced significantly higher ratings to the heat stimuli (P < .009) in all sessions compared to control. For lacrimation level, capsaicin stimulation resulted in a significant increase compared to control (P < .0002) only in the nasal mucosa session.CONCLUSION: Topical application of capsaicin cream to the different branches of the trigeminal nerve caused higher NRS scores along with an altered somatosensory sensitivity. Furthermore, in the nasal mucosa session, a robust local and generalized parasympathetic activation appeared following capsaicin application.
KW - Administration, Intranasal
KW - Capsaicin
KW - Female
KW - Humans
KW - Male
KW - Mouth Mucosa
KW - Nasal Mucosa
KW - Petrolatum
KW - Trigeminal Nerve
U2 - 10.11607/ofph.2303
DO - 10.11607/ofph.2303
M3 - SCORING: Journal article
C2 - 30978271
VL - 33
SP - 318
EP - 330
JO - J ORAL FACIAL PAIN H
JF - J ORAL FACIAL PAIN H
SN - 2333-0384
IS - 3
ER -